51 | 1G2M |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-{[1-METHYL-5-(2-METHYL-BENZOIMIDAZOL-1-YLMETHYL)-1H-BENZOIMIDAZOL-2-YLMETHYL]-AMINO}-BENZAMIDINE |
R11 |
|
0.89 |
SHOW |
52 | 2P94 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-CHLORO-N-((1R,2S) -2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE |
ME4 |
|
0.88 |
SHOW |
53 | 1IQI |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL] METHYL]-2-PIPERAZINECARBOXYLIC ACID |
XMG |
|
0.88 |
SHOW |
54 | 2Y5H |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-[(3AS,4R,5S,8AS,8BR)-4-[2-(5-CHLOROTHIOPHEN-2-YL)-1,3-OXAZOL-4-YL]-1,3-DIOXO-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZIN-2-YL]PROPYL-TRIMETHYL-AZANIUM |
Y5H |
|
0.88 |
SHOW |
55 | 2PR3 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE |
237 |
|
0.88 |
SHOW |
56 | 2XC0 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4--DICARBOXYLIC ACID 3-[(3-FLUORO-4-METHOXY-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} |
8NC |
|
0.88 |
SHOW |
57 | 2Y5F |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(3AS,4R,5S,8AS,8BR)-4-[5-(5-CHLOROTHIOPHEN-2-YL)-1,2-OXAZOL-3-YL]-2-[3-[1-(2-HYDROXYETHYL)PYRROLIDIN-1-IUM-1-YL]PROPYL]-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZINE-1,3-DIONE |
XWG |
|
0.88 |
SHOW |
58 | 1IQF |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2R)-4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-6-OXO-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER |
XMD |
|
0.87 |
SHOW |
59 | 3FFG |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(R)-6-(2'-((3-hydroxypyrrolidin-1-yl)methyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one |
FFG |
|
0.87 |
SHOW |
60 | 2D1J |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE |
D01 |
|
0.86 |
SHOW |
61 | 1WU1 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
5-CHLORO-2-({3-ISOBUTYL-4-[(5-PYRIDIN-4-YLPYRIMIDIN-2-YL)CARBONYL]PIPERAZIN-1-YL}SULFONYL)-1H-INDOLE |
D91 |
|
0.86 |
SHOW |
62 | 1FAX |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-({(3R)-1-[(1Z)-ethanimidoyl]pyrrolidin-3-yl}oxy)phenyl]propanoic acid |
DX9 |
|
0.86 |
SHOW |
63 | 4A7I |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [2-(1--ISOPROPYL-PIPERIDIN-4-YLSULFAMOYL)-ETHYL]-AMIDE |
A7I |
|
0.86 |
SHOW |
64 | 2Y82 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-CHLORO-N-((3S)-2-OXO-1-{4-[(2S)-2-PYRROLIDINYL]PHENYL}-3-PYRROLIDINYL)-2-NAPHTHALENESULFONAMIDE |
930 |
|
0.86 |
SHOW |
65 | 1IOE |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(-)-7-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]TETRAHYDRO-8A-(METHOXYMETHYL)-1'-(4-PYRIDINYL)-SPIRO[5H-OXAZOLO[3,2-A]PYRAZINE-2(3H),4'-PIPERIDIN]-5-ONE |
XMA |
|
0.86 |
SHOW |
66 | 1NFW |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE |
RRR |
|
0.86 |
SHOW |
67 | 4Y6D |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxopyrrolidin-1-yl]-3-fluoro-N,N-dimethylbenzamide |
48U |
|
0.86 |
SHOW |
68 | 1IQH |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[4-HYDROXYMETHYL-1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE |
XMF |
|
0.85 |
SHOW |
69 | 4Y7B |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-chloro-N-{(3S)-1-[(2S)-1-{(1R,5S)-7-[2-(methylamino)ethyl]-3,7-diazabicyclo[3.3.1]non-3-yl}-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide |
44I |
|
0.85 |
SHOW |
70 | 1J17 |
Anionic trypsin-2 | Rattus norvegicus |
P00763 (TRY2_RAT) |
[4-(6-CHLORO-NAPHTHALENE-2-SULFONYL)-PIPERAZIN-1-YL]- (3,4,5,6-TETRAHYDRO-2H-[1,4']BIPYRIDINYL-4-YL)- METHANONE |
ZEN |
|
0.85 |
SHOW |
71 | 2Y80 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-CHLORO-N-{(3S)-1-[(1S)-1-(DIMETHYLAMINO)-2,3-DIHYDRO-1H-INDEN-5-YL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE |
439 |
|
0.85 |
SHOW |
72 | 4ZHA |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(3S)-3-({[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonyl}amino)-2-oxo-2,3-dihydro-1H-pyrrol-1-yl]-3-fluoro-N-methylbenzamide |
4O5 |
|
0.85 |
SHOW |
73 | 1XKA |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
(2S)-(3'-AMIDINO-3-BIPHENYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID |
4PP |
|
0.84 |
SHOW |
74 | 4Y76 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
N~2~-[(6-chloronaphthalen-2-yl)sulfonyl]-N~2~-{(3S)-1-[(2S)-1-(4-methyl-1,4-diazepan-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl}glycinamide |
4O1 |
|
0.84 |
SHOW |
75 | 1FJS |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
N-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-3,5-DIFLUORO-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDIN-4-YL]-N-METHYLGLYCINE |
Z34 |
|
0.84 |
SHOW |
76 | 2Y7X |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
6-CHLORO-N-[(3S)-1-(5-FLUORO-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)-2-OXO-PYRROLIDIN-3-YL]NAPHTHALENE-2-SULFONAMIDE |
MZA |
|
0.83 |
SHOW |
77 | 3UPE |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-6-({1-[(1Z)-ethanimidoyl]piperidin-4-yl}oxy)-2-(propan-2-yl)-1H-indole-4-carboxylic acid |
0CA |
|
0.83 |
SHOW |
78 | 1Y59 |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2,5-BIS-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL1 |
|
0.83 |
SHOW |
79 | 3M37 |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide |
M37 |
|
0.83 |
SHOW |
80 | 1IQG |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[4-HYDROXYIMINOMETHYL-1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE |
XME |
|
0.82 |
SHOW |
81 | 1NFY |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE |
RTR |
|
0.82 |
SHOW |
82 | 2Y5G |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
3-[(3AS,4R,5S,8AS,8BR)-4-[5-(5-CHLOROTHIOPHEN-2-YL)-1,3-OXAZOL-2-YL]-1,3-DIOXO-4,6,7,8,8A,8B-HEXAHYDRO-3AH-PYRROLO[3,4-A]PYRROLIZIN-2-YL]PROPYL-TRIMETHYL-AZANIUM |
FJD |
|
0.82 |
SHOW |
83 | 1IQK |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE |
XMI |
|
0.82 |
SHOW |
84 | 1NFX |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-1-{[1-(2-HYDROXYETHYL)-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]METHYL}PIPERAZIN-2-ONE |
RDR |
|
0.82 |
SHOW |
85 | 1V2K |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
[4-(6-CHLORO-NAPHTHALENE-2-SULFONYL)-PIPERAZIN-1-YL]- (3,4,5,6-TETRAHYDRO-2H-[1,4']BIPYRIDINYL-4-YL)- METHANONE |
ZEN |
|
0.81 |
SHOW |
86 | 1IQJ |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER |
XMH |
|
0.79 |
SHOW |
87 | 2BOK |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
[AMINO (4-{(3AS,4R,8AS,8BR)-1,3-DIOXO-2- [3-(TRIMETHYLAMMONIO) PROPYL]DECAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL}PHENYL) METHYLENE]AMMONIUM |
784 |
|
0.77 |
SHOW |
88 | 4O9V |
Suppressor of tumorigenicity 14 protein | Homo sapiens |
Q9Y5Y6 (ST14_HUMAN) |
N-(trans-4-aminocyclohexyl)-3,5-bis(4-carbamimidoylphenoxy)benzamide |
NT4 |
|
0.76 |
SHOW |
89 | 1Y5U |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2-O-{3-[AMINO(IMINO)METHYL]PHENYL}-5-O-{4-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL4 |
|
0.76 |
SHOW |
90 | 1Y5A |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2-O-{4-[AMINO(IMINO)METHYL]PHENYL}-5-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL2 |
|
0.74 |
SHOW |
91 | 4LXB |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
5-Chloro-thiophene-2-carboxylic acid [(S)-2-[2-difluoromethoxy-3-(2-oxo-piperidin-1-yl)-benzenesulfonylamino]-3-((S)-3-dimethylamino-pyrrolidin-1-yl)-3-oxo-propyl]-amide |
7R9 |
|
0.73 |
SHOW |
92 | 4LOY |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
5-Chloro-thiophene-2-carboxylic acid [(S)-2-[2-chloro-5-fluoro-3-(2-oxo-piperidin-1-yl)-benzenesulfonylamino]-3-(4-methyl-piperazin-1-yl)-3-oxo-propyl]-amide |
6XS |
|
0.72 |
SHOW |
93 | 1F0S |
Coagulation factor X | Homo sapiens |
P00742 (FA10_HUMAN) |
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE |
PR2 |
|
0.72 |
SHOW |
94 | 6T7H |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
macrocycle N14-PR4-A |
MRQ |
|
0.71 |
SHOW |
95 | 4YZU |
Coagulation factor IX | Homo sapiens |
P00740 (FA9_HUMAN) |
N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-4-(4H-1,2,4-triazol-4-yl)benzamide |
4K6 |
|
0.66 |
SHOW |
96 | 1W7G |
Prothrombin | Homo sapiens |
P00734 (THRB_HUMAN) |
N-{(1S)-1-{[4-(3-AMINOPROPYL)PIPERAZIN-1-YL]CARBONYL}-4-[(DIAMINOMETHYLENE)AMINO]BUTYL}-3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE |
MIU |
|
0.66 |
SHOW |
97 | 5TJX |
Plasma kallikrein | Homo sapiens |
P03952 (KLKB1_HUMAN) |
(8E)-3-amino-1-methyl-15-[(1H-pyrazol-1-yl)methyl]-7,10,11,12,24,25-hexahydro-6H,18H,23H-19,22-(metheno)pyrido[4,3-j][1,9,13,17,18]benzodioxatriazacyclohenicosin-23-one |
GBT |
|
0.61 |
SHOW |